about
Group visits as part of ongoing care for improving healthGroup visits as part of ongoing care for improving healthScreening for Colorectal CancerPractice characteristics and prior authorization costs: secondary analysis of data collected by SALT-Net in 9 central New York primary care practices.Future applications of case-based teaching in population-based prevention.Screening for Syphilis Infection in Nonpregnant Adults and Adolescents: US Preventive Services Task Force Recommendation Statement.Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.Screening for Celiac Disease: US Preventive Services Task Force Recommendation Statement.Screening for Preeclampsia: US Preventive Services Task Force Recommendation Statement.Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement.Family physician attitudes in managing obesity: a cross-sectional survey study.Screening for Gynecologic Conditions With Pelvic Examination: US Preventive Services Task Force Recommendation Statement.The impact of prior authorization requirements on primary care physicians' offices: report of two parallel network studies.Screening for Obesity in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Recommendation Statement.Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Recommendation Statement.Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement.Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement.Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement.Folic Acid Supplementation for the Prevention of Neural Tube Defects: US Preventive Services Task Force Recommendation Statement.Developing Recommendations for Evidence-Based Clinical Preventive Services for Diverse Populations: Methods of the U.S. Preventive Services Task Force.A Practice Facilitation and Academic Detailing Intervention Can Improve Cancer Screening Rates in Primary Care Safety Net Clinics.Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Risk Factors: US Preventive Services Task Force Recommendation Statement.The effect of media attention on concern for and medical management of methicillin-resistant Staphylococcus aureus: a multimethod study.Measuring orientation to population-based prevention.Influencing student specialty choice: the 4 Pillars for Primary Care Physician Workforce Development.Vision Screening in Children Aged 6 Months to 5 Years: US Preventive Services Task Force Recommendation Statement.Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: US Preventive Services Task Force Recommendation Statement.Emerging practice concerning vitamin D in primary care.Screening for Adolescent Idiopathic Scoliosis: US Preventive Services Task Force Recommendation Statement.U.S. Preventive Services Task Force Priorities for Prevention Research.Evaluation of a preventive medicine curriculum: incorporating a case-based approach.Case-based teaching in preventive medicine: rationale, development, and implementation.U.S. Preventive Services Task Force Methods to Communicate and Disseminate Clinical Preventive Services Recommendations.Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement.A critical look at prevention: colorectal cancer screening.A user's guide to teaching the C-POP series.Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: US Preventive Services Task Force Recommendation Statement.Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement.
P50
Q24236070-039B90D1-9041-4822-A1D7-54CCD0755D1EQ24242196-F58B7913-6640-4501-BA46-75C0A5BBCB67Q28005564-0F3CE089-23E5-49D2-ADF8-E396ECE59226Q30770681-B99DBDE4-3EB9-48A6-8BD8-E454A9778A3EQ31141972-2E063E3A-5C26-49B4-AAB3-D4C0209593CBQ34530008-7AF9AC48-9284-4713-92A2-F6F2F3170AD2Q34544535-2037ED81-2A97-459A-ACB6-A11880277D46Q34554276-7B2792CC-D4A2-4EDF-AB3E-7E732F517221Q34555841-67A02818-64BE-4209-8FC9-4A38F31A9697Q34556507-6B344C4D-B303-44DC-AC54-B48DE8FC2158Q35602791-E9E7CF63-C20F-4039-9175-11F996A1EDD3Q37834789-8775D82E-E4AE-467E-A67F-2DA749CB79CCQ38071541-E46842CA-7149-48D0-B0E7-80D8033AAB5FQ38717232-6A42EF79-CBB7-490B-9131-438BF9828A5EQ38780209-BCF3CE6B-8D85-4CE2-B2A8-FA59694F1BB1Q38798622-F1381A2B-D572-45B5-B499-DC816E39BD0FQ38908757-03EFC25D-3273-4E7E-9A71-24BB881FC3EDQ38929797-370C0E09-D6A5-4B27-9CBC-D8B3B87BAD26Q38947318-95A73E5B-4FED-4E77-9AEF-87219C38417BQ39001681-47E4B9C2-24D8-44A1-A964-06E26B603393Q39093092-4AE3E37B-B025-4D60-88AF-DE554D30CE3FQ39164841-9C96CDCD-CECC-4B8B-B775-1018F7C34E03Q39404794-CBA57299-F881-4942-BDB5-A1D72C04A31BQ39428778-98E25D23-9558-4F52-8567-B1CA102BAF67Q39873072-B919282E-3010-4998-8499-3954F43F2C18Q40588744-EE0DCDBD-68FD-488A-BF4D-AD355B2A5F48Q43238603-1E1A9915-6F20-4E4F-A93F-976C0EFE1CADQ45066562-B5B53F00-45A7-4A99-940F-0AFE2DE0B3F7Q46320968-A5D50660-1A0A-4F5E-BD02-A3514E2A91B4Q47581702-ED87D6BE-AF33-4D7C-BA65-A887F2B08B82Q47659817-FDB62B55-A63F-417E-BBBA-C9472B74CD07Q47775273-A20E9443-008D-4D5A-910F-5B4E237F6E5DQ47916297-2238584C-4211-46BC-8A20-C5FEDB2563C9Q47916311-40BD267C-B589-408F-9840-68F52E04CDBCQ49647998-87B9132B-2ECC-46DD-9AE6-15C1539AFFD4Q49951147-9D55D0F7-7581-4179-AB78-EA6556580945Q52105597-C1ECB30C-A144-41A1-8B6B-D36B5A570E1BQ52105604-EF379FCD-EC9D-4CCF-9584-DA88B1ED8860Q52574362-7A19CDAB-1B5C-4010-9CF8-0937D25DABC8Q52646634-981CDB3F-3729-4D16-840E-B48F9D38458B
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John Epling
@ast
John Epling
@en
John Epling
@es
John Epling
@nl
John Epling
@sl
type
label
John Epling
@ast
John Epling
@en
John Epling
@es
John Epling
@nl
John Epling
@sl
altLabel
John Epling
@en
prefLabel
John Epling
@ast
John Epling
@en
John Epling
@es
John Epling
@nl
John Epling
@sl
P106
P1153
55988825900
6701333074
P21
P31
P3835
john-epling
P496
0000-0001-9445-8669